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Abstract
Introduction
Though still high, the infant mortality rate in Guinea-Bissau has declined. We aimed to iden-
tify risk factors including vaccination coverage, for infant mortality in the rural population of
Guinea-Bissau and assess whether these risk factors changed from 1992–3 to 2002–3.
Methods
The Bandim Health Project (BHP) continuously surveys children in rural Guinea-Bissau. We
investigated the association between maternal and infant factors (especially DTP and mea-
sles coverage) and infant mortality. Hazard ratios (HR) were calculated using Cox regres-
sion. We tested for interactions with sex, age groups (defined by current vaccination
schedule) and cohort to assess whether the risk factors were the same for boys and girls, in
different age groups in 1992–3 and in 2002–3.
Results
The infant mortality rate declined from 148/1000 person years (PYRS) in 1992–3 to 124/
1000 PYRS in 2002–3 (HR = 0.88;95%CI:0.77–0.99); this decline was significant for girls
(0.77;0.64–0.94) but not for boys (0.97;0.82–1.15) (p = 0.10 for interaction). Risk factors did
not differ significantly by cohort in either distribution or effect. Mortality decline was most
marked among girls aged 9–11 months (0.56;0.37–0.83). There was no significant mortality
decline for girls 1.5–8 months of age (0.93;0.68–1.28) (p = 0.05 for interaction). DTP and
measles coverage increased from 1992–3 to 2002–3.
Conclusions
Risk factors did not change with the decline in mortality. Due to beneficial non-specific
effects for girls, the increased coverage of measles vaccination may have contributed to the
disproportional decline in mortality by sex and age group.
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Introduction
The fourth Millennium Development Goal (MDG4) was to reduce under-five mortality by
two-thirds between 1990 and 2015. Infant mortality constitutes approximately 75% of the
under-five mortality [1]. Although child mortality has declined globally, the decline has been
strongest among older children and in the most developed regions of the world [1]. Under-
five mortality failed to decline as rapidly in Sub-Saharan Africa as in other regions, and Sub-
Saharan Africa still accounted for approximately half of all child deaths worldwide in 2011 [2].
It is therefore important that factors related to mortality decline be identified in order to prior-
itize efforts aimed at reducing child mortality even further and to ensure that the factors are
not removed which could cause subsequent increases in mortality.
Guinea-Bissau, a small country in West Africa, has the seventh highest infant mortality
rate in the world [3]. However, child mortality has declined during the last decades. The Ban-
dim Health Project (BHP) in Guinea-Bissau continuously surveys a random sample of chil-
dren living in the rural areas, and has done so since 1990. Thus, it could be documented that
in these areas the infant mortality rate dropped from 192 per 1000 in the early 1990’s [4], to
135 per 1000 in the 2003–5 [5]. It has been suggested that the observed decline in mortality
may be due to a drop in the malaria prevalence [6, 7], or improved coverage of routine vacci-
nations or even the increasing number of campaigns with vaccines and vitamin A supple-
mentation [8, 9]. However, the main reasons for the decline in mortality have not been
determined.
The aim of the present study was to identify the most important risk factors for infant
mortality and to examine whether changes in these risk factors could explain the decline in
mortality. Identification of factors related to mortality decline could aid in further reduction
of infant mortality. During the high mortality era, several risk factors for infant mortality
have been identified, including low maternal education, low maternal age, and short birth
spacing [10–12]. It is unknown whether these risk factors are still important with declining
mortality. We specifically examined whether the mortality rates and risk factors differed by
age group and sex as coverage of childhood interventions are strongly associated with age,
and sex modifies the effect of many childhood interventions [13]. In addition, we examined
vaccination coverage to assess whether changes in coverage could explain the decline in
mortality.
Methods
Setting
BHP has been working in Guinea-Bissau for more than 35 years, conducting research based
on a routine demographic surveillance system. The demographic surveillance system was
established in five regions in rural Guinea-Bissau in 1990. One hundred clusters, each includ-
ing 100 women of reproductive age and their children under five years of age, were randomly
selected and followed-up every 6 months by mobile teams from BHP. New pregnancies, new
children under five who were either born or moved into the study area are registered at all vis-
its. Information on place of delivery (home, health facility), antenatal care and who assisted
the delivery, is collected at first visit after the birth of a child. Women living in the study areas
are registered at 14–16 years of age and followed until they move out of the area or die. At reg-
istration, women are interviewed about past obstetric history, age, ethnicity, tetanus vaccina-
tions and whether they have attended school. For all children below 5 years of age,
information for assessing child health status is collected at each visit, including vital status, vac-
cinations, use of bed nets and hospitalisations.
Risk factors for infant mortality in Guinea-Bissau
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Risk factors
We compared the distribution of the variables measured for both cohorts and prospectively
assessed the association with mortality for the birth cohorts 1992–1993 and 2002–2003. We
chose the first period as early as possible after the initiation of the data collection, allowing for
a “honey-moon period” to assure that the data collection was running well in all regions and
had been doing so for a while. The second period was chosen to avoid the period from 2005
and onward, when randomised trials of community based malaria treatment and vitamin A
supplementation were underway [14].
We studied the following risk factors which were assessed at the beginning of the surveil-
lance period; sex of the child, region, maternal ethnicity and education, season of birth (rainy
season (June-November) vs. dry season (December-May)), maternal age at birth of the child,
previous loss of child, if the child was delivered with skilled attendance, born at a health care
facility, distance to nearest health facility, number of siblings and twin status. Information on
antenatal care attendance was not collected in 1992–3 and is therefore not included in the pres-
ent study. Likewise, we did not include maternal tetanus vaccination as we did not have this
information at birth for all children and the information may therefore be subject to bias.
During the study period, BCG vaccination and oral polio vaccine (OPV) were recom-
mended at birth, diphtheria-tetanus-pertussis vaccine (DTP) and OPV at 6, 10 and 14 weeks
of age, and measles vaccine (MV) at 9 months [15]. We assessed vaccination coverage in the
two birth cohorts, by assessing coverage at the particular age using information collected dur-
ing the subsequent 12 months. For example, coverage by 2 months of age was assessed among
all children aged 2–13 months at time of health card inspection. Only children with a health
card seen during the one year span were included in the coverage estimates. Furthermore, we
calculated the proportion of children who had DTP as last vaccine, DTP and MV co-adminis-
tered as last vaccine or MV-only as last vaccine.
Statistical analyses
Mortality rates were compared in Cox regression models investigating the influence of mater-
nal and infant risk factors on subsequent death in both univariate and multivariate analyses in
1992–1993 and in 2002–2003, respectively. All live born children contributed time at risk from
the date of birth (or date of registration if identified after birth) until death, migration or 1
year of age whichever came first. We also conducted sub-analyses of risk factors by age groups;
0–45 days of life, 1.5–8 months, and 9–11 months, corresponding to the three major vaccina-
tion ages for BCG, DTP and MV, respectively. When studying the mortality by age groups, the
child contributed time at risk from the beginning of the interval/date of registration (which-
ever came last) until the end of the interval considered. Interactions between risk factors and
sex were also investigated.
In the combined dataset of the two birth cohorts, we investigated whether the risk factors
had changed over time in the two cohorts. We did this by parameterising the model with risk
factor(s), cohort and a term for interaction between the risk factor(s) and cohort both in the
univariate and in the multivariate analyses. Furthermore, we assessed if the association
between the risk factor(s) and mortality had changed over time.
The variables maternal age and distance to health facility/distance to nearest hospital were
tested for a linear relation with the outcome by categorizing the variables into quartiles and
determining whether they revealed a linear trend. None of the continuous variables showed a
linear trend and all values were therefore grouped and included as categorical variables.
“Maternal age” and “number of siblings” were inter-correlated, and so were “health facility
within the village” and “distance to the nearest health care facility”, as well as “region” and
Risk factors for infant mortality in Guinea-Bissau
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“maternal ethnicity”. We therefore only included the exposure which could be targeted in
interventions or where the classification was subject to the least data collection error/inaccu-
racy. Thus, we included; number of siblings, health facility within the village, and region in the
multivariate analyses. Furthermore, place of birth and skilled attendance was only available
among children registered before birth and was therefore not included in the multivariate
analyses.
Guinea-Bissau had two national OPV campaigns in 2002 and two in 2004. We split the
observation time at the OPV campaigns and season to assess whether there were differences in
mortality before and after the campaigns, adjusted for season and age.
Vaccination coverage was not included as a risk factor in the survival analyses as the vacci-
nation status of dead children is uncertain especially in study settings with biannual visits [16].
We therefore only looked at overall vaccination coverage in the cohorts among the survivors,
assuming that these children were representative of the cohort. We assessed difference in cov-
erage from 1992–3 to 2002–3 using binomial regression.
We estimated the potential contribution of the change in coverage of MV and DTP vaccine
on mortality. We based the calculations on recent meta-analyses of the effect of vaccines on
all-cause mortality (16,17). For MV and DTP with/after MV we used the estimates reported in
a recent independent WHO commissioned review. We assumed that having MV as the most
recent vaccine was associated with 46% (35–55%) lower mortality—a difference which was
more pronounced for girls (79%) than for boys (13%) [17]. Contrarily, MV and DTP vaccine
co-administered was associated with 2.3 (1.6–3.4) times higher mortality compared with MV-
only [17]. As argued elsewhere, the WHO commissioned review of DTP includes studies with
methodological problems due to frailty and survival bias (17). We have therefore used the esti-
mate for DTP as most recent vaccine, from a review of studies which document vaccination
status and have prospective follow-up. In this review of DTP studies, DTP was associated with
2.00 (1.50–2.67) fold higher mortality compared with children who were not DTP vaccinated
[18].
Finally, we assessed the impact of vaccination status during the second year of life on sur-
vival after infancy, comparing survival from first date of seen card between 12 and 23 months
of age and six months onwards according to most recent vaccine: MV, DTP with or after MV,
DTP only (no MV) or other/no vaccine, in a Cox regression, using age as the underlying time
scale and stratifying by cohort.
All analyses were performed in STATA version 11.2 (StataCorp, College Station, TX) and
adjusted for cluster sampling using robust variance estimates.
Ethical considerations
The collection of data by the mobile teams has been going on in the current form since 1990 at
the request of the Ministry of Health in Guinea-Bissau and UNICEF to determine child mor-
tality levels in rural parts of Guinea-Bissau. The present study was conducted within the aus-
pices of the OPTIMUNISE project, sponsored by the EU-FP7 programme. Bandim Health
Project, as part of the National Institute of Health in Guinea-Bissau was a co-applicant for the
OPTIMUNISE project; in Danish law register-based studies do not require separate ethical
approval. Hence, no separate ethical permissions were sought for the specific analyses pre-
sented in this paper. Women of reproductive were registered after verbally consenting on
behalf of themselves and their children under five at the time of registration. Written consent
was not required by the ethics committees and was therefore not obtained. Only women who
consented were registered and continuously followed. The ongoing data collection in its cur-
rent form, has been approved by the ethical commission of Guinea-Bissau and Denmark. The
Risk factors for infant mortality in Guinea-Bissau
PLOS ONE | https://doi.org/10.1371/journal.pone.0177984 May 18, 2017 4 / 15
present study was based on data collected years before the data extraction and analysis and to
allow data cleaning by checking missing data and outliers on the original forms, data was avail-
able in non-anonymised form to the main author. The authors have all participated actively in
supervision, data management and data analysis of the routine data collection by the mobile
teams.
Results
In 1992–1993, 3706 live born children were followed; in 2002–3 it was 4526 children. The over-
all infant mortality declined significantly from 148 (95%CI:135–162) per 1000 person years in
1992–3 to 124 (114–136) per 1000 person years in 2002–3 (Table 1), the hazard ratio (HR)
being 0.88 (0.77–0.99). This was not a uniform decline as the mortality rates (MR) for 2002–3
compared with 1992–3 did not change for children aged 1.5–8 months of age (HR = 0.99;0.81–
1.21), among neither boys nor girls (Table 1). The decline was largest among children 9–11
months of age (HR = 0.69;0.54–0.90), mainly due to a mortality reduction among girls in this
age group (HR = 0.56;0.37–0.83) (Table 1). Mortality among neonatal girls also tended to be
lower in 2002–3 than in 1992–3 (HR = 0.73;0.51–1.05) (S1 Table).
Univariate and multivariate risk factor analyses are presented in Table 2. Being twin, being
firstborn and previous loss of child were associated with higher MR in both cohorts. The MR
did not differ according to region, season of birth and maternal schooling. Having no health
center in the village was associated with higher mortality in 1992–3. In 2002–3, long distance
to a hospital was associated with higher MR. The distribution of risk factors did not change
from 1992–3 to 2002–3 except for previous loss of child, which was lower in 2002–3 (Table 2).
Three quarters of the children in both cohorts were born at home, only 13 and 15% percent of
the mothers had attended school and the distributions in maternal age did not differ by
cohort.
Stratified by age group, the main factor associated with mortality decline was sex (S2
Table): In 2002–3, girls aged 0–45 days and 9–11 months had significantly lower MR com-
pared with boys, while mortality of boys and girls did not differ markedly in any age group in
1992–3. We found that distance to nearest hospital, being firstborn, being twin and previous
loss of child mainly were risk factors in younger infants. We saw no statistical interactions
between the examined risk factors and sex (data not shown) and between the examined risk
factor and cohort (Table 2, S2 Table). Four OPV campaigns took place during follow-up time
for the 2002–3 cohort (S3 Table). After splitting the observation time by OPV campaign dates,
26% (993/3782) of the time was spent as exposed to campaign-OPV. Adjusted for age and sea-
son, mortality tended to be lower after the OPV campaigns (HR = 0.90;0.69–1.17) due to a
lower mortality for boys (HR 0.81;0.58–1.14) (data not shown).
We inspected vaccination cards of more than 2000 children in both 1992–3 and 2002–3
and calculated vaccination coverage by age (months) (Fig 1). BCG coverage was higher in
1992–3 compared with 2002–3, but equaled out at 7 months of age. The DTP coverage was
higher in all relevant age groups in 2002–3, as was the MV coverage among 9–11 month chil-
dren in 2002–3 compared with 1992–3 (Fig 1), p<0.001. There was no difference in vaccina-
tion coverage between boys and girls (data not shown). Significantly more children had MV as
their most recent vaccine in 2002–3 (41%) compared with 1992–3 (30%) (RR = 1.38;1.28–1.50)
(Table 3). After infancy, the HR of death was higher among children with DTP> = MV
(HR = 1.44 (0.97–2.15); other vaccines/no vaccine compared with children who had MV as
last vaccine was also associated with increased mortality, the HR being 2.58 (1.54–4.33). Not
having MV-only as last vaccine tended to be worse for girls (HR = 1.63 (1.14–2.32)) than for
boys (HR = 1.24 (0.85–1.81)) (Table 4).
Risk factors for infant mortality in Guinea-Bissau
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Based on the effect estimates from the recent WHO review of the non-specific effects of vac-
cines [17], the increase in the proportion having MV as the most recent vaccine and the lower
proportion having DTP or co-administered DTP and MV as the most recent vaccine
‘explained’ a 6% decline in overall mortality between 1992–3 and 2002–3, equivalent to 19% of
the mortality reduction from 1992–3 to 2002–3. This was 8% (18% of the mortality reduction)
for girls and 2% (11%) for boys. Among children aged 1–8 months (“DTP-age”), the higher
DTP coverage coverage accounted for an estimated 2% increased mortality under the assump-
tion that DTP vaccinated children had double the mortality of DTP unvaccinated children
[18] (S4 Table).
Discussion
Infant mortality declined significantly from 1992–3 to 2002–3. The change was heterogeneous
with respect to sex and age group, being strongest for older girls. Distribution of risk factors
did not change from 1992–3 to 2002–3. Being twin, previous loss of child and being the first
born child were associated with higher MR in both 1992–3 and 2002–3. Vaccination coverage
was higher in 2002–3 except for BCG vaccination. A higher proportion of children had MV-
only as most recent vaccine in 2002–3 compared with 1992–3 and a lower proportion had
Table 1. Crude infant mortality rates in the 1992–3 and 2002–3 birth cohorts for all children and by age groups—Overall and by sex.
Cohort 1992–3 Cohort 2002–3 Hazard ratio 2002–3 vs 1992–
3 (95% CI)*N Deaths/
PYRSa
Mortality rate (per 1000
PYRSa) (95% CI)
N Deaths/
PYRSa
Mortality rate per 1000
PYRSa (95% CI)
All children 3706 471/3185 148 (135–162) 4526 470/3779 124 (114–136) 0.88 (0.77–0.99)
0–45 days 3360 177/381 464 (401–538) 3722 165/411 402 (345–468) 0.90 (0.72–1.11)
1.5–8
months
3461 171/1767 97 (83–112) 4176 199/2081 96 (83–110) 0.99 (0.81–1.21)
9–11
months
3266 123/1037 119 (99–142) 4075 106/1287 82 (68–100) 0.69 (0.54–0.90)
Boysb
All boys 1899 256/1629 157 (139–178) 2304 280/1909 147 (130–165) 0.97 (0.82–1.15)c
0–45 days 1719 97/194 500 (410–611) 1907 101/209 484 (398–588) 1.00 (0.75–1.32)d
1.5–8
months
1772 93/907 103 (84–126) 2111 113/1054 107 (89–129) 1.05 (0.80–1.38) e
9–11
months
1670 66/529 125 (98–159) 2052 66/646 102 (80–130) 0.82 (0.58–1.15)f
Girlsb
All girls 1803 212/1556 136 (119–156) 2221 189/1870 101 (88–117) 0.77 (0.64–0.94)c
0–45 days 1637 78/187 417 (334–520) 1814 64/202 317 (248–405) 0.79 (0.57–1.10)d
1.5–8
months
1687 77/860 90 (72–112) 2064 85/1027 83 (67–102) 0.93 (0.68–1.26)e
9–11
months
1596 57/508 112 (86–145) 2023 40/641 62 (46–85) 0.56 (0.37–0.83)f
*Estimated in a Cox proportional hazards model with age as underlying timescale; 95%CI adjusted for cluster sampling using robust variance estimates
a: PYRS: Person-years
b: Sex missing for 4 children in 1992–3 and for 1 child in 2002–3
c: p = 0.10 for interaction between cohort and sex
d: p = 0.30 for interaction between cohort and sex
e: p = 0.56 for interaction between cohort and sex
f: p = 0.15 for interaction between cohort and sex
https://doi.org/10.1371/journal.pone.0177984.t001
Risk factors for infant mortality in Guinea-Bissau
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Table 2. Distribution (frequencies) and association of potential risk factors with infant mortality in the 1992–3 and 2002–3 birth cohorts (univariate
and multivariate analyses).
Risk factor 1992–3 cohort 2002–3 cohort
N % Mortality
Rate pr.
1000 PYRSa
Hazard
ratio (95%
CI)*
Adjusted
Hazard ratio
(95%CI)*
N % Mortality
Rate pr.
1000 PYRSa
Hazard
ratio (95%
CI)*
Adjusted
Hazard ratio
(95%CI)*
Interaction
with cohort (p-
value)
Univariate/
Multivariate
Sex of childb [p = 0.11] [p = 0.44] [p<0.01] [p<0.01] 0.11 / 0.08
Boy 1899 51% 157 (139–
177)
1.00 (ref) 1.00 (ref) 2304 51% 147 (130–
165)
1.00 (ref) 1.00 (ref)
Girl 1803 49% 136 (119–
156)
0.86 (0.72–
1.04)
0.92 (0.75–
1.13)
2221 49% 101 (88–
116)
0.69 (0.58–
0.83)
0.72 (0.59–
0.87)
Region of birth [p = 0.08] [p = 0.73] [p = 0.58] [p = 0.73] 0.46 / 0.67
Oio 802 22% 167 (139–
201)
1.00 (ref) 1.00 (ref) 945 21% 115 (93–
141)
1.00 (ref) 1.00 (ref)
Biombo 929 25% 157 (132–
187)
0.94 (0.73–
1.22)
0.83 (0.59–
1.17)
1055 23% 133 (111–
159)
1.19 (0.91–
1.57)
1.07 (0.79–
1.47)
Gabu 761 21% 134 (109–
165)
0.81 (0.61–
1.06)
0.87 (0.60–
1.27)
934 21% 114 (93–
139)
0.98 (0.74–
1.31)
1.00 (0.73–
1.36)
Cacheu 534 14% 132 (113–
174)
0.81 (0.59–
1.11)
0.80 (0.56–
1.14)
799 18% 125 (100–
156)
1.12 (0.83–
1.52)
1.04 (0.75–
1.45)
Bafata 680 18% 140 (113–
174)
0.83 (0.63–
1.11)
0.80 (0.56–
1.14)
793 18% 137 (111–
168)
1.19 (0.89–
1.59)
1.22 (0.89–
1.67)
Season of birth [p = 0.42] [p = 0.21] [p = 0.72] [p = 0.60] 0.41/ 0.22
Rainy season 1665 45% 153 (134–
175)
1.00 (ref) 1.00 (ref) 1965 43% 123 (107–
142)
1.00 (ref) 1.00 (ref)
Dry season 2041 55% 144 (127–
162)
0.93 (0.78–
1.11)
0.90 (0.75–
1.07)
2561 57% 125 (111–
141)
1.03 (0.86–
1.24)
1.05 (0.87–
1.28)
Maternal age at
child birth
[p = 0.24] [p = 0.81] 0.26/ NA
<20 years 805 22% 185 (155–
221)
1.00 (ref) 988 22% 150 (125–
181)
1.00 (ref)
20–24 years 942 25% 120 (99–
146)
0.65 (0.50–
0.85)
1347 30% 108 (91–
129)
0.71 (0.55–
0.91)
25–29 years 933 25% 153 (128–
182)
0.83 (0.64–
1.06)
1021 23% 101 (82–
125)
0.65 (0.49–
0.86)
30–34 years 614 17% 139 (111–
174)
0.76 (0.57–
1.01)
662 15% 146 (118–
182)
0.93 (0.70–
1.23)
35+ years 412 11% 143 (109–
189)
0.78 (0.56–
1.09)
508 11% 138 (107–
177)
0.88 (0.65–
1.20)
Ethnicity of
motherd
[p = 0.20] [p = 0.08] 0.07/ NA
Fula 975 26% 150 (126–
179)
1.00 (ref) 849 19% 111 (92–
133)
1.00 (ref)
Balanta 681 18% 183 (151–
221)
1.21 (0.93–
1.57)
1181 26% 107 (85–
134)
0.99 (0.74–
1.32)
Mandinga 744 20% 125 (100–
155)
0.83 (0.63–
1.10)
974 22% 151 (127–
180)
1.38 (1.07–
1.78)
Manjaco 236 6% 106 (70–
161)
0.72 (0.46–
1.14)
350 8% 99 (68–143) 0.94 (0.62–
1.42)
Pepel 789 21% 153 (126–
185)
1.02 (0.79–
1.32)
871 19% 142 (117–
172)
1.33 (1.02–
1.74)
Other 281 8% 141 (100–
198)
0.95 (0.65–
1.39)
292 6% 118 (81–
171)
1.09 (0.72–
1.64)
(Continued)
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Table 2. (Continued)
Risk factor 1992–3 cohort 2002–3 cohort
N % Mortality
Rate pr.
1000 PYRSa
Hazard
ratio (95%
CI)*
Adjusted
Hazard ratio
(95%CI)*
N % Mortality
Rate pr.
1000 PYRSa
Hazard
ratio (95%
CI)*
Adjusted
Hazard ratio
(95%CI)*
Interaction
with cohort (p-
value)
Univariate/
Multivariate
Maternal
schoolinge
[p = 0.74] [p = 0.84] [p = 0.79] [p = 0.85] 0.70/0.97
Never went to
school
3198 87% 148 (135–
164)
1.00 (ref) 1.00 (ref) 3793 85% 126 (114–
139)
1.00 (ref) 1.00 (ref)
Went to school 466 13% 141 (109–
183)
0.95 (0.72–
1.26)
1.04 (0.73–
1.47)
691 15% 118 (93–
151)
0.96 (0.74–
1.25)
0.97 (0.74–
1.28)
Health facility
within the village?
[p = 0.01] [p = 0.04] [p = 0.51] [p = 0.98] 0.16/0.22
Yes 1893 51% 130 (113–
148)
1.00 (ref) 1.00 (ref) 2251 50% 121 (106–
137)
1.00 (ref) 1.00 (ref)
No 1813 49% 167 (148–
189)
1.28 (1.07–
1.53)
1.29 (1.01–
1.66)
2275 50% 128 (113–
145)
1.06 (0.89–
1.27)
1.00 (0.81–
1.23)
Distance to
nearest health
facility (any kind)
[p = 0.04] [p = 0.88] 0.51/NA
<1 km 1893 51% 130 (113–
148)
1.00 (ref) 2275 50% 121 (106–
137)
1.00 (ref)
1–4 km 835 23% 176 (147–
210)
1.35 (1.08–
1.68)
979 22% 135 (112–
163)
1.13 (0.90–
1.41)
5–9 km 662 18% 152 (124–
188)
1.17 (0.91–
1.50)
827 18% 123 (100–
152)
1.03 (0.80–
1.31)
10+ km 316 9% 175 (131–
233)
1.33 (0.97–
1.83)
445 10% 121 (90–
162)
1.00 (0.72–
1.37)
Distance to
nearest hospital
[p = 0.23] [p = 0.50] [p = 0.01] [p = 0.03] 0.64/0.55
<10 km 614 17% 141 (112–
177)
1.00 (ref) 1.00 (ref) 686 15% 96 (74–126) 1.00 (ref) 1.00 (ref)
10–20 km 666 18% 142 (114–
176)
1.01 (0.74–
1.38)
0.96 (0.69–
1.32)
967 21% 120 (98–
146)
1.23 (0.89–
1.71)
1.36 (0.96–
1.92)
21–29 km 685 18% 129 (104–
162)
0.92 (0.67–
1.26)
0.85 (0.59–
1.23)
813 18% 108 (86–
136)
1.11 (0.78–
1.57)
1.15 (0.79–
1.68)
30+ km 1741 47% 160 (141–
182)
1.14 (0.88–
1.48)
1.13 (0.87–
1.46)
2060 46% 142 (126–
162)
1.48 (1.11–
1.98)
1.54 (1.13–
2.11)
Place of giving
birthc,f
[p = 0.78] [0.13] 0.23/NA
At hospital/health
centre
823 27% 143 (120–
171)
1.00 (ref) 800 26% 149 (123–
180)
1.00 (ref)
At home 2198 73% 146 (131–
162)
0.97 (0.78–
1.21)
2308 74% 125 (111–
141)
0.84 (0.67–
1.05)
Born with skilled
attendance?c,g
[p = 0.35] [p = 0.10] 0.08/NA
Yes 1085 37% 136 (115–
162)
1.00 (ref) 1152 38% 145 (123–
170)
1.00 (ref)
No 1814 63% 151 (133–
171)
1.11 (0.90–
1.36)
1852 62% 119 (104–
137)
0.83 (0.66–
1.03)
Was the child a
twin?h
[p<0.01] [p<0.01] [p<0.01] [p<0.01] 0.46/0.41
No 3602 97% 143 (131–
157)
1.00 (ref) 1.00 (ref) 4367 96% 118 (107–
129)
1.00 (ref) 1.00 (ref)
(Continued)
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DTP and MV out of sequence. The higher proportion with MV-only as last vaccine in 2002–3
may have contributed to the stronger mortality decline for girls.
The main strength of this study is the large number of children prospectively surveyed by
BHP. The longstanding registration of pregnancies ensures accurate information on early neo-
natal mortality, which in situations without reconciliation between pregnancies and child rec-
ords are likely to be underreported [19]. Due to the random selection of clusters, we believe
that the sampled children are representative of the rural population of Guinea-Bissau. Further-
more, we were able to investigate several risk factors including both maternal and infant risk
factors assessed prior to the beginning of follow up, and assess their influence on infant mor-
tality without response bias.
Nonetheless, some limitations must be considered. First, we investigate many potential risk
factors which increases the risk of chance findings. In spite of the many factors included, there
were many factors which we did not have information about: We were unable to include fac-
tors related to antenatal care as information on antenatal care was only collected in 2002–3.
Table 2. (Continued)
Risk factor 1992–3 cohort 2002–3 cohort
N % Mortality
Rate pr.
1000 PYRSa
Hazard
ratio (95%
CI)*
Adjusted
Hazard ratio
(95%CI)*
N % Mortality
Rate pr.
1000 PYRSa
Hazard
ratio (95%
CI)*
Adjusted
Hazard ratio
(95%CI)*
Interaction
with cohort (p-
value)
Univariate/
Multivariate
Yes 102 3% 333 (227–
489)
2.23 (1.50–
3.30)
2.51 (1.58–
3.98)
159 4% 334 (244–
457)
2.70 (1.94–
3.75)
2.96 (2.09–
4.21)
Number of older
siblings for the
childi
[p = 0.01] [p<0.01] [p = 0.39] [p<0.01] 0.06/0.08
0 506 15% 224 (182–
274)
1.00 (ref) 1.00 (ref) 671 17% 159 (129–
196)
1.00 (ref) 1.00 (ref)
1–2 1118 34% 133 (112–
158)
0.60 (0.46–
0.78)
0.52 (0.39–
0.71)
1423 36% 123 (104–
145)
0.81 (0.62–
1.06)
0.69 (0.52–
0.91)
3–4 486 15% 151 (118–
193)
0.67 (0.49–
0.93)
0.57 (0.39–
0.82)
590 15% 91 (68–122) 0.59 (0.41–
0.84)
0.47 (0.32–
0.69)
5 1157 35% 135 (114–
160)
0.61 (0.47–
0.80)
0.46 (0.31–
0.68)
1289 32% 137 (117–
160)
0.87 (0.67–
1.13)
0.58 (0.42–
0.80)
Previously lost a
child
[p = 0.52] [p = 0.05] [p<0.01] [p<0.01] 0.10/0.12
No 1754 47% 142 (125–
163)
1.00 (ref) 1.00 (ref) 2550 56% 108 (95–
123)
1.00 (ref) 1.00 (ref)
Yes 1952 53% 153 (135–
172)
1.06 (0.88–
1.27)
1.33 (1.01–
1.77)
1976 44% 145 (128–
164)
1.31 (1.10–
1.58)
1.56 (1.23–
2.00)
*Estimated in a Cox proportional hazards model with age as underlying timescale; 95%CI adjusted for cluster sampling using robust variance estimates
a: PYRS: Person-years
b: Sex missing for 4 children in 1992–3 and for 1 child in 2002–3
c: Only for children registered before birth
d: Ethnicity missing for 9 mothers in 2002–3
e: Education missing for 42 mothers in both 1992–3 and in 2002–3
f: Place of giving birth missing for 83 infants in 1992–3 and for 33 in 2002–3
g: Skilled attendance at birth missing for 205 infants in 1992–3 and for 137 in 2002–3
h: Twin status missing for 2 infants in 1992–3
i: Number of older siblings missing for 439 infants in 1992–3 and for 553 in 2002–3
https://doi.org/10.1371/journal.pone.0177984.t002
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Antenatal care has been associated with lower infant mortality in Ethiopia [20], in South Africa
[12] and in rural India [21]. Information on maternal nutritional status during pregnancy was
not available. Virtually all children (>95%) in both cohorts were still breastfeeding at one year
of age. Changes in breastfeeding practices are therefore unlikely to explain the decline in mor-
tality. Similarly, paternal factors as well as ability to pay for antenatal and delivery services, and
maternal health are not taken into account. HIV has been suggested to underlie a large share
of the infant mortality burden in Africa through transmission from mother to child [22].
Although we are unaware of the HIV status of our study population, a HIV prevalence survey
reported the prevalence in children <5 years to be 0.2% in 2010 [23]. Since we have registered
number of previous births in the beginning of the study, and not their exact year, we were not
able to look at birth spacing as a risk factor for infant mortality, although insufficient spacing
Fig 1. Vaccination coverage with BCG and DTP in the 1992–3 and 2002–3 birth cohorts among
children with a seen vaccination card within 12 months of the assessment age.
https://doi.org/10.1371/journal.pone.0177984.g001
Table 3. Relative risk (RR) of DTP, MV and DTP, MV-only or other/no vaccines as most recent vaccination by 9, 10 and 11 months of age by cohort.
DTP %(n) DTP after MV or DTP and MV
together %(n)
MV-only%(n) Othera or no
vaccines %(n)
1992–3 2002–3 RR (95%CI)* 1992–3 2002–3 RR (95%CI)* 1992–3 2002–3 RR (95%CI)* 1992–3 2002–3
9 months 53%
(1120)
45%
(1175)
0.84 (0.80–
0.89)
18%
(387)
19%
(502)
1.04 (0.92–
1.17)
19%
(404)
29% (755) 1.50 (1.35–
1.67)
8%
(196)
7%
(190)1992–3
n = 2107
2002–3
n = 2622
10 months 42% (864) 33% (840) 0.79 (0.73–
0.85)
25%
(514)
25%
(633)
1.00 (0.90–
1.10)
26%
(531)
36% (927) 1.41 (1.29–
1.54)
7%
(169)
4%
(171)1992–3
n = 2078
2002–3
n = 2571
11 months 33% (668) 25% (631) 0.76 (0.69–
0.83)
31%
(623)
28%
(712)
0.92 (0.84–
1.01)
30%
(606)
41%
(1042)
1.38 (1.28–
1.50)
6%
(145)
3%
(151)1992–3
n = 2042
2002–3
n = 2536
a: Includes BCG only or OPV-only or BCG and OPV only
*RR assessed in binomial regression model with a log-link function; 95% CI adjusted for cluster sampling using robust variance estimates
https://doi.org/10.1371/journal.pone.0177984.t003
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is known to influence the risk of infant mortality [24, 25]. We were only able to look at vacci-
nation coverage overall and not to link vaccination status of the individual child to mortality
during infancy, as we would otherwise risk introducing survival bias [16]. Furthermore, we
were only able to assess vaccination status among children with a vaccination card seen during
the home visits; only slightly more than half of the children had their vaccination card
inspected.
Infant mortality has declined in most low-income countries from the early 1990’s up until
today [3]. West Africa has experienced some of the greatest reductions with falls of on average
25 deaths/1000 births from 1990 until 2000 [26], similar to the numbers in the present study.
Unlike some African regions, where the HIV epidemic has resulted in a recent increase in
child mortality, West Africa has maintained its steady decline [26, 27].
The most important risk factors for infant death in our study were: firstborn, twin status
and previous loss of child—especially among the youngest children. The importance of these
factors have been reported in several other studies of infant mortality [25, 26, 28, 29] and did
not change markedly over time in the present study. A study from nearby Senegal has sug-
gested an effect of season on mortality [24]. We did not see an effect of season of birth in the
present study. However, this could be because we only investigate infant mortality and season
of birth—the effect of season seems to be more pronounced in the older age groups [24, 27].
Higher level of maternal education has been associated with a more active health seeking
behaviour for childhood illnesses [30]. As the level of education is generally low in Guinea-Bis-
sau and the health centres where mothers would seek care, often lack essential drugs and other
necessities, the influence of maternal education may be limited in this setting, and explain why
we neither found any association with maternal education or a consistent effect of distance to
the health centre.
Living close to a hospital (<10 km) was associated with lower risk of infant mortality in
2002–3 –a change from 1992–3 where distance to hospital was not associated with infant mor-
tality. While this could be due to improved treatment regimens in the hospitals or better sup-
plies of essential medicines, we cannot rule out that this could be a chance finding.
Although we found some factors to differ according to mortality risk from 1992–3 to 2002–
3 (e.g. distance to health centre/hospital) most did not and the distributions of risk factors did
not change. Hence, none of the investigated risk factors appear to explain the observed mortal-
ity decline. We therefore looked for other explanations of the mortality decline. Although
many factors may explain the decline in infant mortality, we looked in particular to the effects
of changes in childhood interventions (S3 Table). Childhood interventions have increased in
Table 4. Mortality (Hazard ratios (95%CI)) 6 months after seeing a vaccination card between 12 and 23 months according to having MV, DTP, DTP>
= MV or other or no vaccine as most recent vaccination; overall and by sexa.
Overall Boys Girls
Deaths / person years HR (95%CI)* Deaths / person years HR (95%CI) Deaths / person years HR (95%CI)*
MV-only 46/775 1.00 (ref) 24/411 1.00 (ref) 22/364 1.00 (ref)
DTP 34/611 0.92 (0.59–1.43) 14/296 0.77 (0.40–1.50) 20/315 1.05 (0.57–1.93)
DTP> = MV 53/614 1.44 (0.97–2.15) 24/301 1.38 (0.78–2.44) 29/313 1.52 (0.87–2.65)
Other or no vaccineb 21/132 2.58 (1.54–4.33) 9/71 1.97 (0.91–4.25) 12/61 3.27 (1.61–6.64)
aChildren were followed from first date of seeing the vaccination card between 12 and 23 months and six months onward.
*HR: Hazard Ratio estimated in a Cox proportional hazards model with age as underlying timescale and stratified by cohort; 95%CI adjusted for cluster
sampling using robust variance estimates
bOther vaccine: BCG or OPV or both
https://doi.org/10.1371/journal.pone.0177984.t004
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frequency and coverage over time and may have a major effect on child mortality [31]. Bed net
campaigns became more frequent from 2000 and onwards, however, bed net use at first visit
after birth was much lower in 2002–3 (29%) compared with 1992–3 (68%), and is therefore
unlikely to explain the mortality decline.
Most notably, we saw that the infant mortality declined relatively more among older girls
(9–11 months). An assessment of global sex ratios of infant mortality found girls to have an
increasing survival advantage as total infant mortality declined [32]. Furthermore, sentinel
malaria surveillance from urban Guinea-Bissau shows that the malaria prevalence dropped
markedly from 1995–2003 in Bissau city [33] and thus, this decline may have contributed to
the decline in mortality. However, the decline in malaria prevalence is not likely to explain the
sex-differential decline in mortality among older children or the age-differential decline
between before and after 9 months of age.
Our study offers an alternative explanation as the decline differed both by sex and age,
being stronger for girls than for boys and more pronounced after 9 months of age. In the pres-
ent study, MV coverage between 9 and 11 months was higher and more children had MV as
last vaccine in 2002–3 compared with 1992–3. Furthermore, we found mortality between 9–11
months of age to be lower for girls from 1992–3 to 2002–3 relative to boys, in line with studies
of non-specific effects of MV showing a more beneficial effect for girls [34, 35]. The DTP vac-
cine has been associated with negative non-specific effects on mortality in girls [36]. The cov-
erage of DTP1, DTP2 and DTP3 vaccination was higher at all ages in 2002–3 compared with
1992–3 though the difference was smaller than for MV. Using the meta-estimates from WHO,
we estimated the contribution of increased coverage of MV to be 6% on overall mortality,
roughly accounting for 19% of the mortality decline observed among 9–11 month old infants
from 1992–3 to 2002–3. This decline was 8% for girls and 2% for boys. The actual effects of
MV may be higher. Thus, the increase in MV coverage may contribute to the observed decline
in infant mortality among girls, though it cannot explain the entire decline.
In contrast to the oldest infants, we saw higher or similar HRs in 2002–3 and 1992–3 from
1.5 to 8 months of age where DTP vaccination is likely to be the most recent vaccine. This is
consistent with our calculations showing that DTP may account for a mortality increase of 2%.
Mortality tended to be higher after infancy in girls with DTP or DTP> = MV as the most
recent vaccine six months after vaccine assessment date. Although we did not detect a signifi-
cant overall effect of the OPV campaigns after splitting the observation time, we did see a non-
significant decrease in mortality among boys exposed to OPV campaign compared with boys
who were not exposed to OPV campaign. This is in line with a previous RCT and campaign
studies showing that OPV has strong beneficial effects and that these effects are somewhat
stronger for boys than girls [31,37] The potential beneficial contribution of OPV campaigns is
likely to have been masked by the increase in DTP coverage, and vice versa the OPV cam-
paigns may have averted some of the detrimental effects of DTP among 1–8 month old
children.
Hence, the increase in childhood interventions including routine vaccinations and vaccina-
tion campaigns are likely to have contributed to the observed mortality decline.
Conclusions
Infant mortality declined from 1992–3 to 2002–3. Risk factors did not change over time. The
decline was mainly seen among the oldest infants and among girls. The increased coverage of
MV may have contributed to the decline. More attention should be directed towards under-
standing sex-differential mortality changes.
Risk factors for infant mortality in Guinea-Bissau
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